These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

894 related articles for article (PubMed ID: 17331416)

  • 41. Role of PET in gynecologic malignancy.
    Grigsby PW
    Curr Opin Oncol; 2009 Sep; 21(5):420-4. PubMed ID: 19553814
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characteristics of women with gynecologic cancer who enter clinical trials.
    Luck MB; McIntire M; Blades N; Robinson W
    J Reprod Med; 2005 Jul; 50(7):481-5. PubMed ID: 16130843
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gynecologic cancer in the elderly.
    Termrungruanglert W; Kudelka AP; Edwards CL; Delclos L; Verschraegen CF; Kavanagh JJ
    Clin Geriatr Med; 1997 May; 13(2):363-79. PubMed ID: 9115456
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Diagnostic cytology and histology in the gynecologic malignant tumors].
    Sugishita T
    Gan No Rinsho; 1990 Aug; 36(10):1117-22. PubMed ID: 2214147
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The relationship between telomere length and telomerase activity in gynecologic cancers.
    Wang SJ; Sakamoto T; Yasuda Si S; Fukasawa I; Ota Y; Hayashi M; Okura T; Zheng JH; Inaba N
    Gynecol Oncol; 2002 Jan; 84(1):81-4. PubMed ID: 11748981
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk of endometrial, ovarian, vulvar, and vaginal cancers after a positive cervical cytology followed by negative histology.
    Viikki M; Pukkala E; Hakama M
    Obstet Gynecol; 1998 Aug; 92(2):269-73. PubMed ID: 9699765
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Blood groups of the ABO system and survival rate in gynecologic tumors].
    Marinaccio M; Traversa A; Carioggia E; Valentino L; Coviello M; Salamanna S; Dragone DC; Marinaccio L
    Minerva Ginecol; 1995 Mar; 47(3):69-76. PubMed ID: 7630512
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Screen-detected invasive cervical carcinoma and its clinical significance during the introduction of organized screening.
    Herbert A; Anshu ; Gregory M; Gupta SS; Singh N
    BJOG; 2009 May; 116(6):854-9. PubMed ID: 19371308
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Umbilical metastasis from gynecologic malignancies--a clinical study of 15 cases].
    Yao ZH
    Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):55-7. PubMed ID: 8334940
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Survival of Danish cancer patients 1943-1987. Female genital organs.
    Kjaer SK; Storm HH
    APMIS Suppl; 1993; 33():107-21. PubMed ID: 8512734
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Geriatric gynecology with special reference to malignant tumors].
    Kucera H; Michalica W; Weghaupt K
    Fortschr Med; 1979 May; 97(19):919-22. PubMed ID: 447158
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Pregnancy and oncological diseases].
    Ivanov S
    Akush Ginekol (Sofiia); 2011; 50(5):30-6. PubMed ID: 22482158
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Selective decrease in serum immunoglobulin G1. A tissue nonspecific tumor marker detecting early stages of gynecologic malignant disease with high efficiency.
    Schauenstein E; Lahousen M; Weblacher M; Steinschifter W; Estelberger W; Schauenstein K
    Cancer; 1996 Aug; 78(3):511-6. PubMed ID: 8697398
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Healthcare resource use and costs associated with cervical, vaginal and vulvar cancers in a large U.S. health plan.
    Insinga RP; Ye X; Singhal PK; Carides GW
    Gynecol Oncol; 2008 Nov; 111(2):188-96. PubMed ID: 18757080
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of statin on risk of gynecologic cancers: a meta-analysis of observational studies and randomized controlled trials.
    Liu Y; Qin A; Li T; Qin X; Li S
    Gynecol Oncol; 2014 Jun; 133(3):647-55. PubMed ID: 24736024
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The epidemiology of cancers of the female genital organs].
    Kato I; Tominaga S; Kuroishi T
    Gan No Rinsho; 1989 Jan; 35(1):1-8. PubMed ID: 2646463
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Ultrasound in the study of gynecologic neoplasms].
    Pepe F; Pepe P; Grillo S; Recupero S; Donia A; Panella P; Grasso Leanza P
    Minerva Ginecol; 1996; 48(7-8):303-20. PubMed ID: 8966004
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Recurrence of gynecologic malignancies after combined and primary radiotherapy. Incidence and lapse of time until the diagnosis is made].
    Csaicsich P; Tatra G; Michalica W
    Strahlenther Onkol; 1986 Jul; 162(7):409-13. PubMed ID: 3738739
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relapse and survival in early-stage ovarian cancer.
    Lenhard SM; Bufe A; Kümper C; Stieber P; Mayr D; Hertlein L; Kirschenhofer A; Friese K; Burges A
    Arch Gynecol Obstet; 2009 Jul; 280(1):71-7. PubMed ID: 19093129
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Analysis of characteristics of genital diseases in girlhood].
    Yang D; Yu C; Zhang X
    Zhonghua Fu Chan Ke Za Zhi; 1998 Jun; 33(6):337-9. PubMed ID: 10806669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.